Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trøndelag health study

Archives of Internal Medicine

Volumn 165, Issue 8, 2005, Pages 916-922

  Hagen, Knut ^a,b,c   Zwart, John Anker ^a,b,c,d   Holmen, Jostein ^a   Svebak, Sven ^a   Bovim, Gunnar ^a   Stovner, Lars Jacob ^a,b,c  

^a Department of Clinical Neuroscience ^*

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Norwegian National Headache Centre   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANATOMY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NOCICEPTION; NORWAY; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTENSION; MALE; MUSCULOSKELETAL DISEASES; NORWAY; PAIN; PAIN MEASUREMENT; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 17644379569     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.8.916     Document Type: Article

References (27)

1. Badley EM, Rasooly I, Webster GK. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: findings from the 1990 Ontario Health Survey. J Rheumatol. 1994;21: 505-514.
2. Bergman S, Herrström P, Högström K, Peterson IF, Svennson B, Jacobsson LTH. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol. 2001;28:1369-1377.
3. WHO Scientific Group on the Burden of Musculoskeletal Diseases at the Start of the New Millennium. The Burden of Musculoskeletal Diseases at the Start of the New Millennium. Geneva, Switzerland: World Health Organization; 2003. Technical Report Series, No. 919.
4. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
5. Ghione S. Hypertension-associated hypalgesia: evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences. Hypertension. 1996;28:494-504.
6. Schobel HP, Ringkamp M, Behrmann A, Forster C, Schmieder RE, Handwerker HO. Hemodynamic and sympathetic nerve responses to painful stimuli in normotensive and borderline hypertensive subjects. Pain. 1996;66:117-124.
7. al'Absi M, Petersen KL, Wittmers LE. Blood pressure but not parental history for hypertension predicts pain perception in women. Pain. 2000;88:61-68.
8. Hagen K, Stovner LJ, Vatten L, Holmen J, Zwart JA, Bovim G. Blood pressure and risk of headache: a prospective study of 22,685 adults in Norway. J Neurol Neurosurg Psychiatry. 2002;72:463-466.
9. Wiehe M, Fuchs SC, Moreira LB, Moraes RS, Fuchs FD. Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens. 2002;20:1303-1306.
10. Tzourio C, Gagnière B, El Amrani M, Alpérovitch A, Bousser M-G. Relationship between migraine, blood pressure and carotid thickness: a population-based study in the elderly. Cephalalgia. 2003;23:914-920.
11. Maixner W, Fillingim R, Kincaid S, Sigurdsson A, Harris B. Relationship between pain sensitivity and resting blood pressure in patients with painful temporomandibular disorders. Psychosom Med. 1997;59:503-511.
12. Lundberg U, Melin B, Ekström M, et al. Psychophysiological stress responses, muscle tension, and neck and shoulder pain among supermarket cashiers. J Occup Health Psychol. 1999;4:245-255.
13. Bragdon EE, Light KC, Costello NL, et al. Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain. 2002; 96:227-237.
14. Bruehl S, Chung OY, Ward P, Johnson B, McCubbin JA. The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: the effect of opioid blockade. Pam. 2002; 100:191-201.
15. Lawrence JS. Hypertension in relation to musculoskeletal disorders. Ann Rheum Dis. 1975;34:451-456.
16. Holmen J, Midthjell K, Bjartveit K, et al. The Nord-Trøndelag Health Survey 1984-86: Purpose, Background and Methods: Participation, Non-participation and frequency Distribution. Verdal, Norway: Unit for Health Services Research, National Institute of Public Health; 1990.
17. Holmen J, Midthjell K, Krüger Ø, et al. The Nord-Trendelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Nor J Epidemiol. 2003; 13:19-32.
18. Lund-Larsen PG. Blood pressure measured with a sphygmomanometer and with Dinamap under field condition: a comparison. Nor J Epidemiol. 1997;7:235-241.
19. Kuorinka I, Jonsson B, Kilbom A, et al. Standardised Nordic Questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon. 1987;18:233-237.
20. Franzblau A, Salerno DF, Armstrong TJ, Werner RA. Test-retest reliability of an upper-extremity discomfort questionnaire in an industrial population. Scand J Work Environ Health. 1997;23:299-307.
21. Palmer K, Smith G, Kellingray S, Cooper C. Repeatability and validity of an upper limb and neck discomfort questionnaire: the utility of the Standardized Nordic Questionnaire. Occup Med (Lond). 1999;49:171-175.
22. Guasti L, Zanotta D, Diolisi A, et al. Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade. J Hypertens. 2002;20:485-491.
23. Bruehl S, Carlson CR, McCubbin JA. The relationship between pain sensitivity and blood pressure in normotensives. Pain. 1992;48:463-467.
24. D'Antono B, Ditto B, Sita A, Miller SB. Cardiopulmonary baroreflex stimulation and blood pressure-related hypoalgesia. Biol Psychol. 2000;53:217-231.
25. Bruehl S, McCubbin JA, Harden RN. Theoretical review: altered pain regulatory systems in chronic pain. Neurosci Biobehav Rev. 1999;23:877-890.
26. 158 met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240-1243.
27. Helkamaa T, Männistö PT, Rauhala P, et al. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens. 2003; 21:2365-2374.